PubRank

Drivers of Hypoxia-induced Angiogenesis in Tumor Development

Clinical Trial ID NCT03979833

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT03979833

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Hallmarks of cancer: the next generation. Cell 2011 140.01
2 The hallmarks of cancer. Cell 2000 113.05
3 A genetic model for colorectal tumorigenesis. Cell 1990 44.37
4 The evolutionary history of lethal metastatic prostate cancer. Nature 2015 3.59
5 von Hippel-Lindau disease: a clinical and scientific review. Eur J Hum Genet 2011 2.45
6 The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease. J Neurosurg 2003 2.34
7 VHL, the story of a tumour suppressor gene. Nat Rev Cancer 2015 1.71
8 Genetic analysis of von Hippel-Lindau disease. Hum Mutat 2010 1.55
9 Evolution of VHL tumourigenesis in nerve root tissue. J Pathol 2006 1.11
10 Developmental effects of von Hippel-Lindau gene deficiency. Ann Neurol 2004 0.96
11 Development of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolution. Genome Biol 2014 0.92
12 von Hippel-Lindau disease: surveillance strategy for endolymphatic sac tumors. Genet Med 2011 0.91
13 Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma. Pathol Int 2010 0.85
14 Integra Foundation Award: Long-term natural history of hemangioblastomas in Von Hippel-Lindau disease: implications for treatment. Clin Neurosurg 2006 0.83
15 Nervous system involvement in von Hippel-Lindau disease: pathology and mechanisms. Acta Neuropathol 2013 0.83
16 Essentials and pitfalls in the treatment of CNS hemangioblastomas and von Hippel-Lindau disease. Cent Eur Neurosurg 2010 0.78
17 Preferential loss of the nonimprinted allele for the ZAC1 tumor suppressor gene in human capillary hemangioblastoma. J Neuropathol Exp Neurol 2007 0.77
Next 100